Show 20 5 10 15 20 50 100 250 Sort by year (new to old) Actions Download search results Subscribe to news feed Your filters: cql: author="Fleischmann, Roy M." or (type any "bookEditor journalEditor issueEditor" and editor="Flei... Add to list Journal Article A1 open access Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response : efficacy and safety in patients with rheumatoid arthritis Roy M. Fleischmann, Ricardo Blanco, Stephen Hall, Glen T. D. Thomson, Filip Van den Bosch (UGent) , Cristiano Zerbini, Louis Bessette, Jeffrey Enejosa, Yihan Li, Yanna Song, et al. (2021) ANNALS OF THE RHEUMATIC DISEASES. 80(4). p.432-439 Add to list Journal Article A1 open access Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors : a consensus statement Peter Nash, Andreas Kerschbaumer, Thomas Doerner, Maxime Dougados, Roy M. Fleischmann, Klaus Geissler, Iain McInnes, Janet E. Pope, Desiree van der Heijde, Michaela Stoffer-Marx, et al. (2021) ANNALS OF THE RHEUMATIC DISEASES. 80(1). p.71-87 Add to list Journal Article A1 A phase III, randomized, controlled trial of apremilast in patients with psoriatic arthritis : results of the PALACE 2 trial Maurizio Cutolo, Gary E. Myerson, Roy M. Fleischmann, Frederic Liote, Federico Diaz-Gonzalez, Filip Van den Bosch (UGent) , Helena Marzo-Ortega, Eugen Feist, Kamal Shah, ChiaChi Hu, et al. (2016) JOURNAL OF RHEUMATOLOGY. 43(9). p.1724-1734